Manja Friese-Hamim

3PUBLICATIONS
37CO-AUTHORS
Reaction engineering (excl. nuclear reactions)Proteins and peptidesGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 03, 2024
E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network.

Michaela Poliaková Turan, Rahel Riedo, Matúš Medo

|Nov 08, 2023
Novel Methionine Aminopeptidase 2 Inhibitor M8891 Synergizes with VEGF Receptor Inhibitors to Inhibit Tumor Growth of Renal Cell Carcinoma Models.

Manja Friese-Hamim, Maria J Ortiz Ruiz, Olga Bogatyrova

|Mar 31, 2023
The Preclinical Pharmacology of Tepotinib-A Highly Selective MET Inhibitor with Activity in Tumors Harboring MET Alterations.

Joachim Albers, Manja Friese-Hamim, Anderson Clark

Pageof 1